Logo Image

Video Shorts

Bhavana “Tina” Bhatnagar, DO
0:57
The Significance of the phase 3 frontMIND Data in High-Risk DLBCL
7 hours ago
by
Bhavana Bhatnagar, DO
Jonathan Lee, MD, MSc and Sean Dougherty, MD
0:50
ASCO 2026 Conference Check-In: With Jonathan Lee, MD, MSc and Sean Dougherty, MD
7 hours ago
by
Jonathan Lee, MD, MSc
Sara M. Tolaney, MD, MPH
0:50
Evaluating the Effect of Response Depth on Treatment Outcomes in DESTINY-Breast09
a day ago
by
Sara M. Tolaney, MD, MPH
Mabel Mardones, MD
0:49
Assessing Giredestrant-Based Therapy in ER+, HER2-Negative Advanced/Metastatic Breast Cancer
a day ago
by
Mabel Mardones, MD
ASCO Annual Meeting
3:45
Exploring Notable Posters at the 2026 ASCO Annual Meeting
a day ago
by
Chinmay Jani, MD
Joaquim Bellmunt, MD, PhD
0:58
What Were the Biggest News at the 2026 ASCO Annual Meeting?
2 days ago
by
Joaquim Bellmunt, MD, PhD
Glenn J. Hanna, MD
0:48
Highlighting the Potential Role of Emi-Le in Aggressive ACC Management
3 days ago
by
Glenn J. Hanna, MD
David Chen, MD, Fox Chase Cancer Center
0:37
Examining the Role of Robotics in Prostate Cancer
3 days ago
by
David Chen, MD
MANEUVER Trial Supports Integration of Targeted Therapy Into Upfront TGCT Management
1:05
Potential Applications for Tumor-Informed ctDNA Deep Sequencing in Osteosarcoma
3 days ago
by
R. Lor Randall, MD, FACS
Virginia G. Kaklamani, MD, DSc
0:39
The Evaluation of HER3-DXd in Breast Cancer
4 days ago
by
Virginia G. Kaklamani, MD, DSc
Geoffrey Ku, MD
1:10
What to Know About Toxicity Management With Zanidatamab Regimens From HERIZON-GEA-01
4 days ago
by
Geoffrey Y. Ku, MD
Fred Saad, MD, Montreal Cancer Institute
1:27
Examining Subgroup Data From PSMAaddition in mHSPC
4 days ago
by
Fred Saad, CQ, MD, FRCS, FCAHS
Mark D. Tyson, II, MD, MPH, Mayo Clinic
1:27
What Were the Most Notable News in Bladder Cancer at AUA 2026?
8 days ago
by
Mark D. Tyson, II, MD, MPH
Joaquim Bellmunt, MD, PhD, Dana-Farber
0:32
Unpacking Patient Reported Outcome Data From IMvigor011 in Bladder Cancer
9 days ago
by
Joaquim Bellmunt, MD, PhD
Geoffrey Ku, MD
1:10
HERIZON-GEA-01 Subgroup Analysis Supports Broad Benefit With Zanidatamab Regimen
10 days ago
by
Geoffrey Y. Ku, MD
Rahul Banerjee, MD, spotlights the phase 3 MonumenTAL-3 trial (NCT05455320) among the key multiple myeloma presentations to watch at the 2026 EHA Congress.
2:32
MonumenTAL-3 Leads Key Myeloma Data Set To Emerge at EHA 2026
10 days ago
by
Rahul Banerjee, MD
Ravi B. Parikh, MD, MPP, FACP, Emory
0:55
What Were Some of the Notable Takeaways From the 2026 ASCO Annual Meeting?
10 days ago
by
Ravi B. Parikh, MD, MPP, FACP
Raj Singh, MD
1:53
Highlighting Brain Cancer Radiation Strategies and Needs for World Brain Tumor Day
11 days ago
by
Raj Singh, MD
Pan-RAS Inhibition Opens New Therapeutic Frontiers in Pancreatic Cancer
1:30
Daraxonrasib Represents a Major Breakthrough for Pancreatic Cancer Care
12 days ago
by
Tanios S. Bekaii-Saab, MD
Gopa Iyer, MD
1:11
Unpacking the NEXUS-01 Data in Bladder Cancer
15 days ago
by
Gopa Iyer, MD
Vincent Picozzi, MD
1:00
RASolute 302 Read Out Marks An Exciting New Chapter in Pancreatic Cancer Care
15 days ago
by
Vincent J. Picozzi, MD
Mark Garzotto, MD
0:50
Aglatimagene Besadenovec Emerges in Prostate Cancer
16 days ago
by
Mark Garzotto, MD
Jonathan Lee, MD, MSc, and Chinmay Jani, MD, recap the 2026 Giants of Cancer Care ceremony, where this year’s 14 winners were honored ahead of the 2026 ASCO Annual Meeting.
1:07
Giants of Cancer Care 2026
21 days ago
by
Jonathan Lee, MD, MSc(+1 more)
OncLive National Fellows Forum: Lung Cancer
3:51
Recapping the ASCO 2026 OncLive Fellows Forum: Lung Cancer
21 days ago
by
Chinmay Jani, MD
Gerald Soff, MD
1:30
The “Million-Dollar Question”: Can Romiplostim Improve Outcomes by Maintaining Chemo Dose Intensity?
21 days ago
by
Gerald Soff, MD
Mark Farha, MD, Weill Cornell
0:36
An Analysis of Urinary Proteomics in Bladder Cancer
22 days ago
by
Mark Farha, MD
David Tran, MD, PhD
0:50
Investigating TTFields in Newly Diagnosed Glioblastoma
23 days ago
by
David Tran, MD, PhD
David Y.T. Chen, MD, FACS, Fox Chase Cancer Center
0:39
How Is AI Changing GU Cancer Surgery?
23 days ago
by
David Chen, MD
Paul E. Oberstein, MD
1:06
Inside the Science Behind Personalized Vaccine Development for Pancreatic Cancer
23 days ago
by
Paul E. Oberstein, MD
Jane L. Meisel, MD
1:04
Previewing Updated Data From ASCENT-03 and ASCENT-04 Upcoming at ASCO 2026
24 days ago
by
Jane L. Meisel, MD